T-DM1 EFFICACY AND ACTIVITY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PROGRESSING AFTER FRONTLINE TAXANE PLUS PERTUZUMAB AND TRASTUZUMAB: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY OF THE GRUPPO ITALIANO MAMMELLA (GIM) STUDY GROUP
- Resource Type
- Source
- The Breast. 48:S45
- Subject
Oncology medicine.medical_specialty Taxane business.industry General Medicine medicine.disease Metastatic breast cancer Trastuzumab Internal medicine medicine Surgery Observational study Pertuzumab business medicine.drug - Language
- ISSN
- 0960-9776